9-甲基-β-咔啉
化合物
9-甲基-β-咔啉（英語：9-Methyl-β-carboline，簡稱9-Me-BC）是β-咔啉家族的雜環胺，是一種研究性化學物質。[1]
| 9-甲基-β-咔啉 | |
|---|---|
| |
| |
| IUPAC名 5-Methyl-5H-pyrido[3,4-b]indole 5-甲基-5H-吡啶並[3,4-b]吲哚 | |
| 別名 | 9-Me-BC 9-甲基-9H-β-咔啉 9-甲基去甲哈爾滿 9-MBC N-甲基-β-咔啉 |
| 識別 | |
| CAS號 | 2521-07-5 |
| PubChem | 164979 |
| ChemSpider | 144638 |
| SMILES |
|
| MeSH | C529608 |
| 性質 | |
| 化學式 | C12H10N2 |
| 摩爾質量 | 182.22 g·mol−1 |
| 若非註明，所有數據均出自標準狀態（25 ℃，100 kPa）下。 | |
化學
編輯9-Me-BC是β-咔啉的甲基化衍生物，分子式為C12H10N2。
它可以通過對游離鹼β-咔啉（去甲哈爾滿）進行埃施魏勒-克拉克反應來製備[來源請求]
生物效應
編輯多巴胺能神經元細胞培養物的體外研究表明，在長期給予魚藤酮後，酪氨酸羥化酶和相關轉錄因子的表達增加，神經突生長增加，神經元再生，炎症細胞因子的表達減少。[2]在原代中腦多巴胺能神經元細胞培養物的研究中，該物質增加了分化的多巴胺能神經元的數量，並產生了更高水平的與多巴胺能分化相關的轉錄因子。[3]9-甲基-β-咔啉還在體外抑制神經毒素前體MPTP向多巴胺能神經毒素MPP+的氧化過程。[4]
齧齒動物體內研究表明，海馬體多巴胺水平升高，徑向臂迷宮測試中的空間學習表現得到改善，並且海馬齒狀回的樹突生長增加，[5]在帕金森病動物模型中，左側表達酪氨酸羥化酶的神經元數量恢復，而注射MPP+後紋狀體中此類細胞的數量減少了50%。[6]
參見
編輯參考資料
編輯- ^ Polanski, W; Enzensperger, C; Reichmann, H; Gille, G. The exceptional properties of 9-methyl-β-carboline: Stimulation, protection and regeneration of dopaminergic neurons coupled with anti-inflammatory effects.. J Neurochem. 2010, 113 (6): 1659–1675. PMID 20374418. doi:10.1111/j.1471-4159.2010.06725.x
.
- ^ Polanski, W; Enzensperger, C; Reichmann, H; Gille, G. The exceptional properties of 9-methyl-β-carboline: Stimulation, protection and regeneration of dopaminergic neurons coupled with anti-inflammatory effects.. J Neurochem. 2010, 113 (6): 1659–1675. PMID 20374418. doi:10.1111/j.1471-4159.2010.06725.x .
- ^ Hamann, J; Wernicke, C; Lehmann, J; Reichmann, H; Rommelspacher, H; Gille, G. 9-Methyl-β-carboline up-regulates the appearance of differentiated dopaminergic neurones in primary mesencephalic culture.. Neurochem. Int. 2008, 52 (4–5): 688–700. PMID 17913302. S2CID 24226033. doi:10.1016/j.neuint.2007.08.018.
- ^ Herraiz, T; Guillén, H. Inhibition of the bioactivation of the neurotoxin MPTP by antioxidants, redox agents and monoamine oxidase inhibitors.. Food Chem. Toxicol. 2011, 49 (8): 1773–1781. PMID 21554916. doi:10.1016/j.fct.2011.04.026. hdl:10261/63126.
- ^ Gruss, M; Appenroth, D; Flubacher, A; Enzersperger, C; Bock, J; Fleck, C; Gille, G; Braun, K. 9-Methyl-β-carboline-induced cognitive enhancement is associated with elevated hippocampal dopamine levels and dendritic and synaptic proliferation.. J Neurochem. 2012, 121 (6): 924–931. PMID 22380576. doi:10.1111/j.1471-4159.2012.07713.x .
- ^ Wernicke, C; Hellmann, J; Zieba, B; Kuter, K; Ossowska, K; Frenzel, M; Bencher, NA; Rommelspacher, H. 9-Methyl-beta-carboline has restorative effects in an animal model of Parkinson's disease.. Pharmacol Rep. 2010, 62 (1): 35–53. PMID 20360614. doi:10.1016/s1734-1140(10)70241-3.
- ^ Polanski, W; Reichmann, H; Gille, G. Stimulation, protection and regeneration of dopaminergic neurons by 9-methyl-β-carboline: a new anti-Parkinson drug?. Expert Rev Neurother. 2011, 11 (6): 845–860. PMID 21651332. S2CID 24899640. doi:10.1586/ern.11.1.
- ^ Vignoni M, Rasse-Suriani FA, Butzbach K, Erra-Balsells R, Epe B, Cabrerizo FM. Mechanisms of DNA damage by photoexcited 9-methyl-β-carbolines. Org Biomol Chem. 2013, 11 (32): 5300–9. PMID 23842892. doi:10.1039/c3ob40344k.
